Lentiviral Vector Contract Development and Manufacturing Organizations Market, By Component (Lentiviral promoter, Lentiviral fusion tags and Lentivirus packaging systems), By Disease Indication (Cancer, Genetic disorders, Infectious diseases and Veterinary disease), By End User (Pharmaceutical & biotech and Academic research), By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
REPORT HIGHLIGHT
Lentiviral Vector Contract Development and Manufacturing Organizations Market size was valued at USD 152.2 Million in 2022, expanding at a CAGR of 6.2% from 2023 to 2030.
Contract Development and Manufacturing Organizations (CDMOs) are specialized in lentiviral vector production. These organizations offer services for the development, manufacturing, and production of lentiviral vectors for gene therapy, cell therapy, and other Disease Indications.
Lentiviral Vector Contract Development and Manufacturing Organizations Market- Market Dynamics
- Growing emphasis on cell and gene therapies is expected to propel the Lentiviral Vector Contract Development and Manufacturing Organizations demand.
Numerous hereditary and acquired diseases, such as cancer, rare genetic abnormalities, and autoimmune diseases, have showed great promise in the treatment with gene and cell treatments. The need for lentiviral vectors, which are essential resources for delivering therapeutic genes to target cells, is anticipated to rise as more possible therapeutic targets are discovered and verified. Ex vivo gene editing and modified cell treatments are just a couple of the therapeutic uses for lentiviral vectors\' adaptability and versatility. The investigation of novel therapeutic modalities and individualized medical strategies has increased demand for CDMOs using lentiviral vectors.
Further, the development of gene and cell therapies has received support from regulatory organizations like the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA). The need for trustworthy lentiviral vector manufacturing partners has increased because of the quicker regulatory procedures and other incentives they have offered to support the research and marketing of these novel medicines.
Lentiviral Vector Contract Development and Manufacturing Organizations Market- Key Insights
- As per the analysis shared by our research analyst, the global Lentiviral Vector Contract Development and Manufacturing Organizations market is estimated to grow annually at a CAGR of around 6.2% over the forecast period (2023-2030)
- The Lentiviral Vector Contract Development and Manufacturing Organizations industry is projected to grow at a significant rate due to the growing focus on manufacturing industries.
- Based on Disease Indication, cancer segment was predicted to show maximum market share in the year 2022.
- Based on End User, pharmaceutical & biotech segment is expected to hold significant market share by 2030.
- Based on Component segmentation, lentiviral promoter segment was the leading in 2022
- On the basis of region, North America was the leading revenue generator in 2022.
Lentiviral Vector Contract Development and Manufacturing Organizations Market- Segmentation Analysis:
The Global Lentiviral Vector Contract Development and Manufacturing Organizations Market is segmented on the basis of Component, Disease Indication, End User, and Region.
The market is divided into four categories based on Component: lentiviral promoter, lentiviral fusion tags, lentivirus packaging systems and others. The lentiviral promoter segment dominates the market. Increasing demand from medical sector for lentiviral contract developments is contributing to market growth.
The market is divided into five categories based on Disease Indication: cancer, genetic disorders, infectious diseases, veterinary disease, and others. The cancer segment dominates the market. Increasing prevalence of cancer and its other disease forms is expected to boost the market growth.
The market is divided into three categories based on End User: pharmaceutical & biotech, academic research, and others. The pharmaceutical & biotech segment dominates the market. The rising demand from medical development in pharma sector is increasing the segment growth.
Lentiviral Vector Contract Development and Manufacturing Organizations Market- Geographical Insights
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.
Lentiviral Vector Contract Development and Manufacturing Organizations Market- Competitive Landscape:
Owing to the fast development in medical, and rising demand from pharmaceutical sector, which influence the lentiviral vector contract development and manufacturing organizations market. Several companies promote their products, including corporate websites, and Disease Indications, are used by businesses to sell their solutions & Disease Indications. Composite manufacturers compete on various factors, such as composite pricing, performance, composite creation, and marketing. reputation, and availability. Some of the primary techniques, and strategies used by corporations to consolidate their reach and expand their market share include new product launches, R&D expenditure, developing its distribution network and mergers & acquisitions. Some of the recent developments are mentioned below.
Recent Developments:
- In 2021, Oxford Biomedica signed a new three-year development and supply agreement with Boehringer Ingelheim to manufacture and supply viral vectors.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL LENTIVIRAL VECTOR CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS MARKET KEY PLAYERS
- Thermo Fisher Scientific Inc.
- Oxford Biomedica
- Charles River Laboratories International, Inc.
- Creative Biogene
- GenScript ProBio
- Merck KGaA
- Catalent Inc.
- Ask Bio
- Lonza
- Curia Global, Inc.
- Wuxi Advanced Therapies
- SIRION Biotech GmbH
- VGXI, Inc.
- Yposkesi
- Oxford Genetics Ltd.
GLOBAL LENTIVIRAL VECTOR CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS MARKET, BY COMPONENT
- Lentiviral promoter
- Lentiviral fusion tags
- Lentivirus packaging systems
- Others
GLOBAL LENTIVIRAL VECTOR CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS MARKET, BY DISEASE INDICATION
- Cancer
- Genetic disorders
- Infectious diseases
- Veterinary disease
- Others
GLOBAL LENTIVIRAL VECTOR CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS MARKET, BY END USER
- Pharmaceutical & biotech
- Academic research
- Others
GLOBAL LENTIVIRAL VECTOR CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Lentiviral Vector Contract Development and Manufacturing Organizations Market Overview
1.1. Study Scope
2. Executive Summary
2.1. Market Snippet
2.1.1. Lentiviral Vector Contract Development and Manufacturing Organizations Market Snippet by Component
2.1.2. Lentiviral Vector Contract Development and Manufacturing Organizations Market Snippet by Disease Indication
2.1.3. Lentiviral Vector Contract Development and Manufacturing Organizations Market Snippet by End User
2.1.4. Lentiviral Vector Contract Development and Manufacturing Organizations Market Snippet by Country
2.1.5. Lentiviral Vector Contract Development and Manufacturing Organizations Market Snippet by Region
2.2. Competitive Insights
3. Lentiviral Vector Contract Development and Manufacturing Organizations Key Market Trends
3.1. Lentiviral Vector Contract Development and Manufacturing Organizations Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Lentiviral Vector Contract Development and Manufacturing Organizations Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Lentiviral Vector Contract Development and Manufacturing Organizations Market Opportunities
3.4. Lentiviral Vector Contract Development and Manufacturing Organizations Market Future Trends
4. Lentiviral Vector Contract Development and Manufacturing Organizations Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Lentiviral Vector Contract Development and Manufacturing Organizations Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Lentiviral Vector Contract Development and Manufacturing Organizations Market Landscape
6.1. Lentiviral Vector Contract Development and Manufacturing Organizations Market Share Analysis, 2022
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Lentiviral Vector Contract Development and Manufacturing Organizations Market – By Component
7.1. Overview
7.1.1. Segment Share Analysis, By Component, 2022 & 2030 (%)
7.1.2. Lentiviral promoter
7.1.3. Lentiviral fusion tags
7.1.4. Lentivirus packaging systems
7.1.5. Others
8. Lentiviral Vector Contract Development and Manufacturing Organizations Market – By Disease Indication
8.1. Overview
8.1.1. Segment Share Analysis, By Disease Indication, 2022 & 2030 (%)
8.1.2. Cancer
8.1.3. Genetic disorders
8.1.4. Infectious diseases
8.1.5. Veterinary disease
8.1.6. Others
9. Lentiviral Vector Contract Development and Manufacturing Organizations Market – By End User
9.1. Overview
9.1.1. Segment Share Analysis, By Disease Indication, 2022 & 2030 (%)
9.1.2. Pharmaceutical & biotech
9.1.3. Academic research
9.1.4. Others
10. Lentiviral Vector Contract Development and Manufacturing Organizations Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
10.2. North America
10.2.1. Overview
10.2.2. Lentiviral Vector Contract Development and Manufacturing Organizations Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.2.4. North America Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
10.2.5. North America Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
10.2.6. North America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Lentiviral Vector Contract Development and Manufacturing Organizations Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
10.3.6. Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.3.8. Italy
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.8.3. Italy Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
10.3.8.4. Italy Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
10.3.8.5. Italy Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.3.9. United Kingdom
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.9.3. United Kingdom Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
10.3.9.4. United Kingdom Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.3.10. France
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.10.3. France Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
10.3.10.4. France Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
10.3.10.5. France Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.3.11. Russia
10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.11.2. Russia Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
10.3.11.3. Russia Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
10.3.11.4. Russia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.3.12. Netherlands
10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.12.2. Netherlands Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
10.3.12.3. Netherlands Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
10.3.12.4. Netherlands Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.3.13. Sweden
10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.13.2. Sweden Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.3.14. Poland
10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.14.2. Poland Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
10.3.14.3. Poland Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
10.3.14.4. Poland Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.3.15. Rest of Europe
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.15.3. Rest of the Europe Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
10.3.15.4. Rest of the Europe Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Lentiviral Vector Contract Development and Manufacturing Organizations Key Manufacturers in Asia Pacific
10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.4.4. Asia Pacific Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
10.4.5. Asia Pacific Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
10.4.6. Asia Pacific Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.4.7. India
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.7.3. India Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
10.4.7.4. India Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
10.4.7.5. India Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.4.8. China
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.8.3. China Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
10.4.8.4. China Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
10.4.8.5. China Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.4.12. Thailand
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.12.3. Thailand Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
10.4.12.4. Thailand Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
10.4.12.5. Thailand Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.4.13. Indonesia
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.13.3. Indonesia Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
10.4.13.4. Indonesia Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
10.4.13.5. Indonesia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.15.3. Rest of APAC Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
10.4.15.4. Rest of APAC Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.5. Latin America
10.5.1. Overview
10.5.2. Lentiviral Vector Contract Development and Manufacturing Organizations Key Manufacturers in Latin America
10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.5.4. Latin America Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
10.5.5. Latin America Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
10.5.6. Latin America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.6. Middle East and Africa
10.6.1. Overview
10.6.2. Lentiviral Vector Contract Development and Manufacturing Organizations Key Manufacturers in Middle East and Africa
10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.6.4. Middle East and Africa Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
10.6.5. Middle East and Africa Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.6.8. United Arab Emirates
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.8.3. United Arab Emirates Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
10.6.8.4. United Arab Emirates Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.13.3. Rest of MEA Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
10.6.13.4. Rest of MEA Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
11. Key Vendor Analysis- Lentiviral Vector Contract Development and Manufacturing Organizations Industry
11.1. Competitive Dashboard
11.2. Company Profiles
11.2.1. Thermo Fisher Scientific Inc.
11.2.2. Oxford Biomedica
11.2.3. Charles River Laboratories International, Inc.
11.2.4. Creative Biogene
11.2.5. GenScript ProBio
11.2.6. Merck KGaA
11.2.7. Catalent Inc.
11.2.8. Ask Bio
11.2.9. Lonza
11.2.10. Curia Global, Inc.
11.2.11. Wuxi Advanced Therapies
11.2.12. SIRION Biotech GmbH
11.2.13. VGXI, Inc.
11.2.14. Yposkesi
11.2.15. Oxford Genetics Ltd.
12. 360 Degree Analyst View
13. Appendix
13.1. Research Disease Indicationology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
